Syntex adjuvant formulation

11/01/2014 - "The purpose of the present study is to evaluate smear layer generation and residual debris after using self-adjusting file (SAF) or rotary instrumentation and to compare the debris and smear layer removal efficacy of the SAF cleaning/shaping irrigation system against final agitation techniques. "
11/01/2014 - "The EndoActivator, EndoVac, PUI, and SAF irrigation groups increased the efficacy of irrigating solutions on the smear layer and debris removal. "
02/01/2012 - "The aim of this study was to compare the SAF with the ProTaper rotary file system, evaluating debris and smear layer removal and the presence of bacteria by using microbiological and scanning electron microscopy (SEM) evaluation. "
04/01/2010 - "The aim of this study was to evaluate the cleaning ability of the Self-Adjusting File (SAF) system in terms of removal of debris and smear layer. "
11/01/2014 - "The SAF instrumentation group generated less smear layer and yielded cleaner canals compared to rotary instrumentation. "

10/01/2009 - "Awareness of this entity is helpful in distinguishing SAF from other myxoid soft tissue tumors occurring there. "
07/14/2011 - "The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients."
06/01/2007 - "The SAF was computed from relative risks established in the American study Cancer Prevention Study II and from estimates of the prevalence of smoking in the CR from a nationwide study conducted in 2002. "
05/01/2004 - "This study uses linear regression, age-adjusted rates from http://www.seer.cancer.gov/canques, and the formula SAF = (1- ((rate in the unexposed) / (rate in the exposed))). "
11/01/2015 - "TRANSLATION AND LINGUISTIC VALIDATION OF THE MODIFIED MYELOPROLIFERATIVE NEOPLASM SYMPTOM ASSESSMENT FORM - TOTAL SYMPTOM SCORE (MMPN-SAF TSS) FOR USE IN 26 COUNTRIES."

02/01/2011 - "SAF also demonstrated significant XO (key enzyme linked to inflammation) inhibitory activity, which revealed its therapeutic potential as an antioxidant and XO inhibitor. "
08/01/2009 - "These findings show that transcriptional regulation of downstream inflammation-responsive genes by SAF/MAZ/Pur-1 is likely to be more complex than previously assumed. "
08/01/2009 - "SAF-3, a novel splice variant of the SAF-1/MAZ/Pur-1 family, is expressed during inflammation."
08/15/2006 - "An inflammation-responsive transcription factor, SAF (for SAA activating factor), has been implicated in the sustained expression of amyloidogenic SAA under chronic inflammatory conditions. "
12/01/1998 - "We have previously reported an element of the SAA promoter, designated SAA-activating sequence (SAS), that is involved in the inflammation-induced SAA expression, and a nuclear factor, SAS-binding factor (SAF), that interacts with the SAS element has been identified previously (A. "

07/01/2013 - "The work highlights the efficacy of the receptor as a corrective measure against negative influence of SAF on functional parameters of spermatozoa as well as fertility and presents receptor as a potential therapeutic intervention against SAF induced infertility."
07/01/2013 - "In vivo studies showed that receptor (50 μg) could alleviate SAF induced infertility in female Balb/c mice following a single intravaginal application before mating. "
01/01/2013 - "SAF induced impairment of sperm parameters, and infertility was observed to be due to interaction of SAF with sperm surface receptor component as, when purified receptor was introduced, receptor completely inhibited all the detrimental effects induced by SAF. "
04/11/1985 - " There is a possibility that the association noted between the use of Lippes Loop or Saf-T-Coil and tubal infertility may have been due to chance since the number of users of these devices in this sample was small. "
01/01/2013 - "Intravaginal administration of SAF could lead to infertility in Balb/c mice. "

07/01/2013 - "Mean SAF value was significantly higher in the DFU group in comparison with the control group, even after adjustment for other diabetes complications (3.2±0.6 arbitrary units vs. 2.9±0.6 arbitrary units; P=0.001). "
01/01/2013 - "SAF-DM's value for diabetes/IGT screening is further supported by its established performance in predicting diabetic complications."
12/01/2012 - "SAF is related to chronic diabetes complications. "
09/01/2013 - "Measurements of skin autofluorescence (SAF) allow for a simple and noninvasive quantification of tissue advanced glycation end-products (AGEs), a marker linked to the risk of diabetes complications. "
11/01/2012 - "In patients with insulin-dependent type 2 diabetes mellitus and CAD, presence of SAF correlates with both glycemic control and diabetic complications. "